Sanofi
SNY
$46.61
Share price
-2.26%
Change (1 day)
-17.66%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Earnings for Sanofi (SNY)
Earnings in 2023 (TTM): $8.39 B
According to Sanofi's latest financial reports the company's current earnings (TTM) are $8.39 B. a decrease over its 2022 earnings that were of $11.49 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Sanofi from 2005 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | $8.39 B | -26.95% |
| 2022 | $11.49 B | 20.23% |
| 2021 | $9.55 B | |
| 2019 | $3.60 B | -37.02% |
| 2018 | $5.71 B | -15.81% |
| 2017 | $6.79 B | -6.94% |
| 2016 | $7.29 B | 16.34% |
| 2015 | $6.27 B | -23.83% |
| 2014 | $8.23 B | 18.78% |
| 2013 | $6.93 B | -17.88% |
| 2012 | $8.44 B | 4.4% |
| 2011 | $8.08 B | 1.77% |
| 2010 | $7.94 B | -11.24% |
| 2009 | $8.95 B | |
| 2005 | $6.56 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 102.16% | 🇺🇸 USA |
 Novartis NVS | $9.43 B | 12.42% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | -61.09% | 🇺🇸 USA |
 Novo Nordisk NVO | $15.42 B | 83.79% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | $6.66 B | -20.62% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | -21.93% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -63.85% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.44 B | 0.53% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | -10.25% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -95.18% | 🇮🇱 Israel |